Prostate Cancer

A patient with prostate cancer under active surveillance may encounter the fear that their cancer might progress, causing stress and anxiety. However, HIIT workouts may help put them at ease.

After a metastatic prostate cancer diagnosis, Robert Hollander decided to bring together his love of wine and his journey with cancer to create a foundation to support the research field.

As PSA testing recommendations change and the debate surrounding testing continues, people with a high-risk of prostate cancer and their families need to stay informed.

“I believe the key for many is to turn prostate cancer from a lethal disease to a chronic disease. That’s what we’re trying to do,” says an expert at the University of California, San Francisco.

Walking has played a key role in my cancer experience, as it helps my mental and physical health.

Talzenna Plus Xtandi lengthened time to progression in men with metastatic castration-resistant prostate cancer.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about survivorship in prostate cancer.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about the long-term effects associated with a prostate cancer diagnosis.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Dr. Daniel P. Petrylak about PSMA, what it is and how it is advancing the prostate cancer landscape.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Tony Crispino about the importance of patient-physician communication in prostate cancer.

As part of its Speaking Out video series, on behalf of Fans for the Cure, CURE® spoke with Tony Crispino about seeking support after a prostate cancer diagnosis.

Men with metastatic castration-resistant prostate cancer lived longer without their disease progressing when treated with Rubraca compared to standard of care.

Men with prostate cancer who were “fast metabolizers” of caffeine from coffee tended to have better prostate cancer-specific survival, according to recent research.

When talking about cancer, it’s OK to use profanities sometimes.

From NFL Hall of Famer Shannon Sharpe and Monty Python member sharing their cancer diagnoses to “Good Morning America” promoting Be The Match, here’s what’s happening in the cancer space this week.

When my husband was diagnosed with prostate cancer in his mid 40s, we opted for a more aggressive treatment strategy, which led him being cancer-free and able to enjoy a healthy sex life.

Two years of the hormone treatment androgen-deprivation therapy (ADT) after radiotherapy and radical prostatectomy tended to improve metastasis-free survival for patients with prostate cancer, study results showed.

With nearly one-year of additional follow-up, adding Keytruda to the combination of abiraterone acetate and the steroid prednisone shows continued benefit in men with metastatic castration-resistant prostate cancer.

BNT211-01, a novel CAR-T cell therapy, was efficacious in treating patients with CLDN6-positive, relapsed/refractory solid cancers, according to a small clinical trial.

From actress Jane Fonda giving an update on her cancer, to a patient with leukemia proving he was at the Sept. 11 attacks in New York City with an old newspaper clipping, here’s what’s happening in the cancer space this week.

There’s a flip side to the trauma of cancer — a better appreciation of the small things in everyday life.

Even though I had no symptoms, my prostate cancer was caught thanks to frequent follow-ups with my doctor.

I recently was asked to speak at a banquet for my cancer center and saw that as a great opportunity to recognize those who cared for me.

From the death of a football Hall of Famer and a golf champion to actress and former Nickelodeon star Jennette McCurdy discussing her mother’s breast cancer in her memoir, “I’m Glad My Mom Died,” here’s what’s happening in the cancer space this week.

Radiotherapy with standard of care for the treatment of patients with low-burden metastatic prostate cancer had minimal effects on quality of life over a five-year follow-up period.